19/02/2020 : THERADIAG helps establish new WHO international standard for biotherapy monitoring

Croissy-Beaubourg, February 19, 2020, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, has been actively involved in the establishment and validation of a new World Health…

Continue Reading 19/02/2020 : THERADIAG helps establish new WHO international standard for biotherapy monitoring

13/02/2020 : Excellent results generated by new i-Tracker® kits presented at ECCO Congress

TRACKER, a comprehensive range on the market allowing all patients treated with Infliximab to be monitored Croissy-Beaubourg, February 13, 2020, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics…

Continue Reading 13/02/2020 : Excellent results generated by new i-Tracker® kits presented at ECCO Congress